National Health Stock Price, News & Analysis

National HealthCare Corporation (NYSE American: NHC) will pay a quarterly common dividend of $0.64 per share to shareholders of record on December 31, 2025, payable on January 30, 2026.

The release reiterates standard forward-looking cautionary language noting risks including litigation, insurance availability, labor and cost pressures, regulatory changes, and Medicare/Medicaid payment variability, with references to the company’s SEC reports for additional details.

National HealthCare Corporation (NYSE American: NHC), the nation's oldest publicly traded senior health care company, has reported strong financial results for Q2 2025. The company achieved net operating revenues of $374.91 million, marking a significant 24.7% increase from $300.66 million in Q2 2024.

The revenue growth was driven by a 9.6% increase in same-facility net operating revenues and the strategic acquisition of White Oak Management, Inc. completed on August 1, 2024. While GAAP net income decreased to $23.72 million from $26.84 million year-over-year, the adjusted net income showed remarkable growth of 64.7%, reaching $25.71 million compared to $15.61 million in Q2 2024.

National HealthCare Corporation (NYSE American: NHC) has declared a quarterly dividend of $0.64 per common share. The dividend will be paid on October 31, 2025, to shareholders of record as of September 30, 2025.

NHC, recognized as the nation's oldest publicly traded long-term health care company, maintains its commitment to shareholder returns through regular dividend payments.

Land & Buildings Investment Management issued a critical analysis of National Healthcare Corp's (NHC) lease negotiation with National Health Investors (NHI), which expires in 2026. The investment firm, which holds a short position in NHC, outlines three potential scenarios for NHC, all potentially negative. The best-case scenario could see NHC losing 19% of EBITDA with fair market rent negotiations, while the worst case could result in a 38% EBITDA loss if NHI leases to another operator. The analysis criticizes the historically below-market lease terms orchestrated by the Adams brothers, who ran both companies. Recent developments, including Robert Adams' narrow board reelection victory, suggest NHI now has leverage in negotiations. Land & Buildings warns that aggressive negotiation tactics by NHC could risk regulatory scrutiny and significant shareholder value destruction.

National HealthCare Corporation (NYSE American: NHC) reported strong financial results for Q1 2025. Net operating revenues reached $373.7 million, up 25.7% from $297.2 million in Q1 2024. This growth was driven by an 8.5% increase in same-facility revenues and the strategic acquisition of White Oak Management in August 2024, which added 22 healthcare facilities to NHC's portfolio.

The company's GAAP net income rose to $32.2 million ($2.07 per diluted share), compared to $26.2 million ($1.69 per diluted share) in Q1 2024. Adjusted net income, excluding unrealized gains in marketable equity securities, increased by 61.4% to $24.8 million ($1.59 per diluted share) from $15.4 million ($0.99 per diluted share) in the same period last year.

W. Andrew "Andy" Adams, son of NHC founder Dr. Carl Adams, has announced his retirement from the National HealthCare Corporation (NYSE American: NHC) Board of Directors, effective May 8, 2025. Adams had a distinguished career at NHC spanning over three decades, joining as an Executive Officer in 1972 and serving as President (1974-2004) and CEO (1981-2004). During his leadership tenure, NHC experienced significant growth, with revenue reaching $521 million in 2004 and market capitalization expanding from $57 million in 1983 to $431 million in 2004. Adams also served as Board Chairman from 1994 to 2008, contributing to NHC's development as a leader in senior healthcare.

National HealthCare Corporation (NYSE American: NHC) has announced a quarterly dividend increase of 4.9%, raising the payment to 64 cents per common share. The dividend will be paid on August 1, 2025, to shareholders of record as of June 30, 2025. NHC, recognized as the nation's oldest publicly traded long-term health care company, maintains its commitment to shareholder returns while acknowledging various business risks including regulatory changes, litigation, Medicare and Medicaid payment adjustments, and economic conditions.

National HealthCare (NYSE American: NHC) reported strong financial results for 2024, with net operating revenues and grant income reaching $1.31 billion, a 14.5% increase from 2023's $1.14 billion. The growth was driven by a 9.4% increase in same-facility revenues and the strategic acquisition of White Oak Manor on August 1, 2024, which added 22 healthcare operations to NHC's portfolio.

The company's GAAP net income for 2024 rose to $101.9 million ($6.53 per diluted share), up from $66.8 million ($4.34 per diluted share) in 2023. Adjusted net income, excluding unrealized gains in marketable equity securities, increased 39.9% to $76.9 million ($4.93 per diluted share) from $54.9 million ($3.55 per diluted share) in 2023.

National HealthCare (NYSE American: NHC), the nation's oldest publicly traded long-term health care company, has declared a quarterly dividend of 61 cents per common share. The dividend will be paid on April 25, 2025, to shareholders of record as of March 28, 2025.

The company included standard forward-looking statements cautioning investors about various risks, including potential liabilities, claims, litigation, economic conditions, regulatory changes, Medicare and Medicaid payment adjustments, and other factors that could affect future performance.